NEW YORK: Pfizer and its partner BioNTech plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine by Mar 1, 2021, while staying within the study. The trial's Vaccine Transition Option allows all participants aged 16 or older the ...
from Latest News https://ift.tt/385iqcO
Pfizer and BioNTech to offer COVID-19 vaccine to volunteers who got placebo
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment